Gloria Iacoboni

33PUBLICATIONS
161CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jul 08, 2026
Cellular therapy in mantle cell lymphoma: recommendations from the EBMT practice harmonisation and guidelines committee.

|Jun 10, 2026
Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.

|Feb 14, 2026
CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis.

Victor Navarro, Gloria Iacoboni, Sergi Camarillas

|Jan 16, 2026
Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries.

Alex Y Ge, William B Feldman, Martin F Kaiser

|Dec 31, 2025
Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy.

Javier Varela-González-Aller, Mario Andrés Sánchez-Salinas, Iñaki Troconiz

|Oct 29, 2025
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3.

Tom van Meerten, Marie José Kersten, Gloria Iacoboni

Pageof 6

Frequent Collaborators

11 joint publications

Marion Subklewe

9 joint publications

Víctor Navarro

6 joint publications

Pere Barba

5 joint publications

Veit L Bücklein